7ROAD (00797) announced its interim results, with a profit attributable to shareholders of 51.99 million yuan, an increase of 91.67% year-on-year.
Seventh Avenue (00797) announced its interim results for the six months ending June 30, 2026, with the group achieving revenue of RMB 226 million, an increase of 27.87% year-on-year; profit attributable to the company's owners for the period was RMB 51.99 million, an increase of 91.67% year-on-year; earnings per share were RMB 0.02.
7ROAD (00797) announced its interim results for the six months ended June 30, 2026. The group achieved a revenue of RMB 226 million, representing a year-on-year increase of 27.87%; the profit attributable to company owners for the period was RMB 51.99 million, a year-on-year increase of 91.67%; earnings per share were RMB 0.02.
The announcement stated that the increase in revenue was primarily due to the positive performance of the groups online games in the first half of 2026, with self-developed game revenue of approximately RMB 213 million, an increase of about 52.9% compared to approximately RMB 139 million for the six months ended June 30, 2025.
Related Articles

CHINA HUAJUN GP (00377): Li Gang appointed as Chairman, Executive Director, and CEO

BRIGHTSTAR TECH (08446) announced its interim results, with a profit attributable to shareholders of HKD 4.237 million, a decrease of 39.65% compared to the same period last year.

CSPC PHARMA (01093): The Phase I clinical trial of SYH2092 injection for weight management in adults with overweight or obesity has officially launched at the first research center in China.
CHINA HUAJUN GP (00377): Li Gang appointed as Chairman, Executive Director, and CEO

BRIGHTSTAR TECH (08446) announced its interim results, with a profit attributable to shareholders of HKD 4.237 million, a decrease of 39.65% compared to the same period last year.

CSPC PHARMA (01093): The Phase I clinical trial of SYH2092 injection for weight management in adults with overweight or obesity has officially launched at the first research center in China.

RECOMMEND





